Skip to main content
. 2019 Jul 4;85(6):E1084–E1094. doi: 10.1093/neuros/nyz229

FIGURE 1.

FIGURE 1.

Impact of treatment dose rate on post-treatment outcomes for vestibular schwannomas following definitive GKRS (Elekta AB). Solid line = lower dose rate, < 2.675 Gy/min; dashed line = higher dose rate, ≥ 2.675 Gy/min. A, Clinical tumor control. B, Radiographic progression-free survival. C, Post-treatment freedom from progressive hearing loss and FND.